Biotech China 2014

Proteomics: Eli Lilly

Total Score People Score Events Score
11 11 6
Date Event Presentation Speakers
October 17, 2013 14th Annual G Protein-Coupled Receptor (GPCR) Retreat Early safety assessment: when and how much Derek Leishman
January 26, 2009 Biomarker Assay Development Utilizing a LC/MS/MS (MRM) Quantitative Targeted Biomarker Panel to Elucidate Multiple Biological Changes Simultaneously Jon Butler
November 5, 2007 Second Annual Biomarkers Europe Nov (05-06) BIOMARKERS FOR EARLY CLINICAL TRIALS: Biomarkers in Early Oncology Clinical Trials (08:05-08:35) Michael Lahn
BIOMARKERS FOR EARLY CLINICAL TRIALS (08:00-12:15) Michael Lahn
BIOMARKER QUALIFICATION AND VALIDATION (15:45-17:45) Charles Benson
BIOMARKER QUALIFICATION AND VALIDATION: Biomarker Validation: Why, Which, and How? (15:45-16:15) Charles Benson
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Concurrent Session 6: Systems Medicine Richard B GAYNOR
September 30, 2007 BioProcess International Conference & Exhibition Production & Economics of Biopharmaceuticals, Strategies for Flexible Facility Design and Capacity Optimization (07:00 - 11:30) Kristi M. Huntington
Scaling Up from Bench through Commercialization , Best Practices for Strategic Scale Up Decisions (07:00 - 12:15) Jose M. Hanquier
Strategies for Flexible Facility Design and Capacity Optimization : Technology Transfer: A Streamlined Business Approach to Lessen the Burden on a Multi-Project Facility Kristi M. Huntington
Best Practices for Strategic Scale Up Decisions: Design Space for Late Stage Process Optimization: Application to Process Robustness at Commercial Scale Jose M. Hanquier
Scaling Up from Bench through Commercialization ; Regulatory and Quality Considerations (13:45 - 17:45) Jeffrey C. Baker
Regulatory and Quality Considerations : Chairperson's Remarks Jeffrey C. Baker
Plenary Session ; Keynote Presentations and Featured Discussion : Interactive Panel Discussion on the Future of Downstream Processing: How Best to Handle Higher Bioreactor Outputs and Greater Product Demands Alan Klotz
Production & Economics of Biopharmaceuticals ; Scaling Up from Bench through Commercialization (07:30 - 12:00) Jeffrey C. Baker, Eric C. Jensen
Discussion Session 2B: Quality by Design: Aspiration and Application Jeffrey C. Baker, Eric C. Jensen
Discussion Session 2A: Modeling Up and Scaling Down: Use of Model Systems in Validation Assurance Jeffrey C. Baker
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Pre-Conference Workshops; Biomarker Assay Development and Validation: Part II Emerging Technology Platforms for Biomarker Assay Development in the Clinical Setting (13:30-14:00) Sunil Kadam
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.